A retrospective, single center cohort study evaluating long-term outcomes and related prognostic factors of adalimumab maintenance treatment in Japanese patients with crohn's disease.
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2017
At a glance
- Drugs Adalimumab (Primary) ; Azathioprine; Mercaptopurine; Prednisolone
- Indications Crohn's disease
- Focus Pharmacodynamics; Therapeutic Use
- 05 Jan 2017 New trial record